Latest Cholesterol Stories
First Positive Regulatory Agency Determination for a PCSK9 Inhibitor THOUSAND OAKS, Calif., May 22, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN) today announced that the Committee for Medicinal
LONDON, May 20, 2015 /PRNewswire/ -- This report analyzes the worldwide markets for Cholesterol Testing in Million Units by the following Product Segments:
Both Standard and Aggressive Treatment Provide Similar Benefit in Reducing Atherosclerosis SAN DIEGO, May 7, 2015 /PRNewswire/ -- Treating both low-density lipoprotein (LDL), or "bad,"
Vitamin B5 Derivative Combined with Artichoke for Cholesterol Management* New York, NY (PRWEB) April 30, 2015 Life Extension® is offering a new
Submission of Application in Japan Marks an Important Milestone in Strategic Partnership With Amgen Astellas BioPharma THOUSAND OAKS, Calif., March 20, 2015 /PRNewswire/ -- Amgen (NASDAQ: AMGN)
FDA approves oral therapy as a first-in-class treatment BALTIMORE, March 17, 2015 /PRNewswire-USNewswire/ -- Asklepion Pharmaceuticals, LLC. today announced that the U.S.
Analysis From Prespecified Exploratory Endpoints Presented in Late-Breaking Session at ACC.15 Showed Repatha Plus Standard of Care Lowered Cardiovascular Events THOUSAND OAKS, Calif., March
Data From PCSK9 Inhibitor Study Support Regulatory Filing in Japan THOUSAND OAKS, Calif., March 14, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new detailed data from the Phase
Data Evaluating the Effect of Repatha(TM)(Evolocumab) on LDL-C and Cardiovascular Events to be Featured in Late-Breaking Session THOUSAND OAKS, Calif., March 2, 2015 /PRNewswire/ -- Amgen (NASDAQ:AMGN)
TEL AVIV, Israel, March 2, 2015 /PRNewswire/ -- Galmed Pharmaceuticals Ltd.
- To say in too many words; to express verbosely.
- To express in too many words: sometimes used reflexively.
- The leading idea or a repeated phrase, as of a song or ballad; the refrain; burden.
More Images (1 images) »